Advertisement
UK markets open in 2 hours 2 minutes

  • NIKKEI 225

    37,738.81
    -721.27 (-1.88%)
     

  • HANG SENG

    17,295.93
    +94.66 (+0.55%)
     

  • CRUDE OIL

    82.92
    +0.11 (+0.13%)
     

  • GOLD FUTURES

    2,327.00
    -11.40 (-0.49%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • Bitcoin GBP

    51,591.03
    -2,151.12 (-4.00%)
     

  • CMC Crypto 200

    1,389.59
    -34.51 (-2.42%)
     

  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     

  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

BUZZ-AstraZeneca: EPS, sales beat to help shares up a 2nd day

Reuters - UK Focus

** AstraZeneca L>, one of Europe's worst performing healthcare stocks this year, seen opening as much as 3 pct higher following a better-than-expected Q2

** Co raised its rev forecast for the year, earnings outlook same as previous view reflects R&D spending

** Stock down 7.9 pct so far this year up to Wednesday's close vs a 23 pct rise for European healthcare stocks

** Morgan Stanley (Xetra: 885836 - news) , which rates AZN an "underweight," says pressure on US growth platforms continues while sustainability of asset disposals to fund pipeline remains a source of concern for investors (RM (LSE: RM.L - news) : vikram.subhedar.thomsonreuters.com@reuters.net)